Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01312779 · ClinicalTrials.gov registry record · NA
Magna Mitral - 23mm
A NA study, sponsored by Edwards Lifesciences.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT01312779 is a NA study that has completed, run by Edwards Lifesciences. The registered enrollment target is 39 participants.
The verdict
NCT01312779, a NA study, has completed, sponsored by Edwards Lifesciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to obtain human clinical data that demonstrates that the size 23mm Carpentier-Edwards PERIMOUNT Magna mitral pericardial valve, model 7000TFX, is a safe and effective replacement heart valve.
Interventions
- DEVICE Implantation of CEP Magna Mitral Model 7000TFX
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2011-03 |
| Est. Completion | 2018-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01312779
The ClinicalTrials.gov registry entry for NCT01312779 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Implantation of CEP Magna Mitral Model 7000TFX is the first listed.
NCT01312779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01312779 about?
NCT01312779 is a clinical study titled "Magna Mitral - 23mm". The purpose of this clinical study is to obtain human clinical data that demonstrates that the size 23mm Carpentier-Edwards PERIMOUNT Magna mitral pericardial valve, model 7000TFX, is a safe and effective replacement heart valve.
What is the current status of trial NCT01312779?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2011-03. Estimated completion is 2018-11.
What interventions are being tested in trial NCT01312779?
The interventions under investigation include: Implantation of CEP Magna Mitral Model 7000TFX (DEVICE).
Who is sponsoring clinical trial NCT01312779?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.